Evaluating the Current State of Play in 2024 to Convey the Key Priorities for LNP Development
Time: 10:15 am
day: Pre-Conference LNP 101 Day
Details:
- Considering the necessary steps to advance more LNP drug products through to the clinic
- Spotlighting the current disease indications accessible for LNPs as well as the gaps currently unreachable
- Reviewing the breadth of drug substances currently delivered within LNPs, as the field moves beyond mRNA
